• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Better Therapeutics

Digital therapeutics open up new opportunities in medicine

May 5, 2022 By Sean Whooley

A wide range of companies are aiming to make waves through digital therapeutic offerings, and each is doing things differently. “We are seeing tremendous momentum for the DTx industry, with more and more products coming to market and gaining commercial coverage and recent signals from the White House and Congress demonstrating their interest and recognition […]

Filed Under: Business/Financial News, Digital Health, Health Technology, Neurological, Software / IT Tagged With: Better Therapeutics, DarioHealth Corp, Digital therapeutics, Pear Therapeutics, Sanofi

Better Therapeutics reaches key milestones for prescription digital therapeutics

April 6, 2022 By Sean Whooley

Better Therapeutics (Nasdaq:BTTX) announced today that it hit multiple key research milestones as it validates its digital therapeutics. San Francisco-based Better Therapeutics develops prescription digital therapeutics designed to deliver a novel form of cognitive-behavioral therapy for treating cardiometabolic diseases, potentially improving key measures related to type 2 diabetes, hypertension and more. Get the full story at […]

Filed Under: Big Data, Business/Financial News, Clinical Trials, Diabetes, Digital Health, Drug-Device Combinations, Health Technology, Software / IT Tagged With: Better Therapeutics

Better Therapeutics completes enrollment in type 2 diabetes study

November 19, 2021 By Sean Whooley

Better Therapeutics (NSDQ:BTTX) announced that it completed patient enrollment in a study of its digital therapeutic in treating diabetes. San Francisco–based Better Therapeutics’ BT-001 prescription digital therapeutic delivers a novel form of cognitive-behavioral therapy to patients with uncontrolled type 2 diabetes. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Clinical Trials, Diabetes, Digital Health, Featured, Health Technology, Neurological, News Well, Patient Monitoring Tagged With: Better Therapeutics

Better Therapeutics closes SPAC merger, debuts on Nasdaq

October 29, 2021 By Sean Whooley

Better Therapeutics announced today that it completed its merger with Mountain Crest Acquisition Corp and has gone public on the Nasdaq. San Francisco-based Better Therapeutics announced its intention to merge with Mountain Crest, a publicly-traded, special purpose acquisition corporation (SPAC), in April. Last month, the company confirmed its expectations for the $113 million SPAC merger to go through […]

Filed Under: Business/Financial News, Diabetes, Digital Health, Drug-Device Combinations, Featured, Mergers & Acquisitions, Wall Street Beat Tagged With: Better Therapeutics, Mountain Crest SPAC, SPACs

Better Therapeutics expects $113M SPAC merger to go through in October

September 9, 2021 By Sean Whooley

Better Therapeutics announced today that it will go public through a $113 million merger with Mountain Crest Acquisition Corp II Mountain Crest, a publicly-traded, special purpose acquisition corporation (SPAC), will acquire Better Therapeutics in a deal expected to be completed in the summer of this year, with the company continuing to operate as Better Therapeutics […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Mergers & Acquisitions, Patient Monitoring Tagged With: Better Therapeutics, Mountain Crest SPAC

Better Therapeutics secures $50M debt facility for digital diabetes treatment tech

August 25, 2021 By Sean Whooley

Better Therapeutics announced today that it secured a loan debt facility worth up to $50 million from Hercules Capital. The debt facility provides up to $150 million in total financing when combined with the proceeds from going public through a $113 million merger with SPAC Mountain Crest Acquisition Corp II and a PIPE investment. Get the full story […]

Filed Under: Business/Financial News, Diabetes, Digital Health, Drug-Device Combinations, Funding Roundup, Health Technology, Software / IT Tagged With: Better Therapeutics

Better Therapeutics initiates real-world study for digital therapeutic for diabetes

April 14, 2021 By Sean Whooley

Better Therapeutics announced today that it commenced a real-world evidence study to evaluate its treatment for Type 2 diabetes. Collaborating with Steward Health Care, Better Therapeutics is evaluating BT-001, an investigational, prescription digital therapeutic (PDT) designed to deliver a novel form of cognitive-behavioral therapy to patients with uncontrolled Type 2 diabetes, according to a news release. […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations Tagged With: Better Therapeutics

MedTech 100 roundup: Industry roars back

April 12, 2021 By Sean Whooley

In the blink of an eye, the medtech industry exited its spring slump and neared its all-time best performance levels. MassDevice‘s MedTech 100 Index offered signs of a rebound last week and has built on that momentum, registering a final tally of 109.39 points on April 9. That represents a 2.9% increase from the 106.26-point mark […]

Filed Under: Business/Financial News, Featured, Funding Roundup, Initial Public Offering (IPO), MassDevice Earnings Roundup, Mergers & Acquisitions, Wall Street Beat Tagged With: Better Therapeutics, Google, Hologic, INSIGHTEC, LumiraDX, MedTech 100 Index, Medtronic, Olympus, Outset Medical, Pixium Vision, Second Sight, Varian

Better Therapeutics to go public via $113M merger with SPAC

April 7, 2021 By Sean Whooley

Better Therapeutics announced today that, through a $113 million merger with Mountain Crest Acquisition Corp II, it will go public. Mountain Crest, a publicly-traded, special purpose acquisition corporation (SPAC), will acquire Better Therapeutics in a deal expected to be completed in the summer of this year, with the company continuing to operate as Better Therapeutics […]

Filed Under: Business/Financial News, Diabetes, Digital Health, Drug-Device Combinations, Featured, Health Technology, Mergers & Acquisitions, Software / IT, Wall Street Beat Tagged With: Better Therapeutics, Mountain Crest SPAC

Primary Sidebar

DeviceTalks Weekly

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS